These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD. Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465 [Abstract] [Full Text] [Related]
27. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. Qi H, Li M, Wronski TJ. J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319 [Abstract] [Full Text] [Related]
28. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats. Kidder LS, Schmidt IU, Evans GL, Turner RT. Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204 [Abstract] [Full Text] [Related]
32. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model. Lane NE, Kimmel DB, Nilsson MH, Cohen FE, Newton S, Nissenson RA, Strewler GJ. J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776 [Abstract] [Full Text] [Related]
33. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats. Erben RG, Bromm S, Stangassinger M. Osteoporos Int; 1998 May; 8(1):82-91. PubMed ID: 9692082 [Abstract] [Full Text] [Related]
34. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S. J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644 [Abstract] [Full Text] [Related]
35. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY. Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596 [Abstract] [Full Text] [Related]
36. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats. Wang L, Orhii PB, Banu J, Kalu DN. Bone; 2001 Feb; 28(2):202-7. PubMed ID: 11182379 [Abstract] [Full Text] [Related]
37. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I. Kostenuik PJ, Harris J, Halloran BP, Turner RT, Morey-Holton ER, Bikle DD. J Bone Miner Res; 1999 Jan; 14(1):21-31. PubMed ID: 9893062 [Abstract] [Full Text] [Related]
38. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats. Rhee Y, Won YY, Baek MH, Lim SK. J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792 [Abstract] [Full Text] [Related]
39. Response of femoral neck to estrogen depletion and parathyroid hormone in aged rats. Li M, Wronski TJ. Bone; 1995 May; 16(5):551-7. PubMed ID: 7544601 [Abstract] [Full Text] [Related]